Opus Genetics, Inc. License Costs (Deprecated 2018-01-31)
Opus Genetics, Inc. (IRD) reported License Costs (Deprecated 2018-01-31) of $101.38 thousand for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LicenseCosts · last filed 2018-05-04
- Opus Genetics, Inc. license costs (deprecated 2018-01-31) for the quarter ending 2014-09-30 was $101.38K, a 1.18% increase year-over-year.
- Opus Genetics, Inc. license costs (deprecated 2018-01-31) for the quarter ending 2014-06-30 was $95.41K, a 21.29% decline year-over-year.
- Opus Genetics, Inc. license costs (deprecated 2018-01-31) for the quarter ending 2014-03-31 was $72.02K, a 47.23% decline year-over-year.
- Opus Genetics, Inc. license costs (deprecated 2018-01-31) for the quarter ending 2013-12-31 was $70.30K, a 45.32% decline year-over-year.
- Opus Genetics, Inc. license costs (deprecated 2018-01-31) for fiscal 2013 was $428.20K, a 0.67% decline from fiscal 2012.
- Opus Genetics, Inc. license costs (deprecated 2018-01-31) for fiscal 2012 was $431.10K, a 21.05% decline from fiscal 2011.
- Opus Genetics, Inc. license costs (deprecated 2018-01-31) for fiscal 2011 was $546.03K, a 65.50% increase from fiscal 2010.
- Opus Genetics, Inc. license costs (deprecated 2018-01-31) for fiscal 2010 was $329.93K.
| Period end | License Costs (Deprecated 2018-01-31) 3 month | License Costs (Deprecated 2018-01-31) 6 month | License Costs (Deprecated 2018-01-31) 9 month | License Costs (Deprecated 2018-01-31) 12 month | License Costs (Deprecated 2018-01-31) 12 month as first filed | License Costs (Deprecated 2018-01-31) 132 month | License Costs (Deprecated 2018-01-31) 135 month | License Costs (Deprecated 2018-01-31) 138 month | License Costs (Deprecated 2018-01-31) 141 month | License Costs (Deprecated 2018-01-31) 144 month | License Costs (Deprecated 2018-01-31) 147 month | License Costs (Deprecated 2018-01-31) 150 month | License Costs (Deprecated 2018-01-31) 153 month | License Costs (Deprecated 2018-01-31) 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | $101.38K 10-Q · filed 2014-11-12 | $196.79K derived: sum of 2 quarters · filed 2014-11-12 | $268.81K 10-Q · filed 2014-11-12 | $339.11K derived: sum of 4 quarters · filed 2014-11-12 | ||||||||||
| 2014-06-30 | $95.41K 10-Q · filed 2014-08-13 | $167.43K 10-Q · filed 2014-08-13 | $237.73K derived: sum of 3 quarters · filed 2014-08-13 | $337.93K derived: sum of 4 quarters · filed 2014-11-12 | ||||||||||
| 2014-03-31 | $72.02K 10-Q · filed 2014-05-14 | $142.32K derived: sum of 2 quarters · filed 2014-05-14 | $242.52K derived: sum of 3 quarters · filed 2014-11-12 | $363.73K derived: sum of 4 quarters · filed 2014-11-12 | $3.03M 10-Q · filed 2014-05-14 | |||||||||
| 2013-12-31 | $70.30K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $170.50K derived: sum of 2 quarters · filed 2014-11-12 | $291.71K derived: sum of 3 quarters · filed 2014-11-12 | $428.20K 10-K · filed 2014-03-21 | $2.96M 10-K · filed 2014-03-21 | |||||||||
| 2013-09-30 | $100.20K 10-Q · filed 2014-11-12 | $221.41K derived: sum of 2 quarters · filed 2014-11-12 | $357.91K 10-Q · filed 2014-11-12 | $486.47K derived: sum of 4 quarters · filed 2014-11-12 | $2.89M 10-Q · filed 2013-11-13 | |||||||||
| 2013-06-30 | $121.22K 10-Q · filed 2014-08-13 | $257.71K 10-Q · filed 2014-08-13 | $386.27K derived: sum of 3 quarters · filed 2014-08-13 | $508.84K derived: sum of 4 quarters · filed 2014-08-13 | $2.79M 10-Q · filed 2013-08-12 | |||||||||
| 2013-03-31 | $136.49K 10-Q · filed 2014-05-14 | $265.06K derived: sum of 2 quarters · filed 2014-05-14 | $387.63K derived: sum of 3 quarters · filed 2014-05-14 | $465.00K derived: sum of 4 quarters · filed 2014-05-14 | $2.67M 10-Q · filed 2013-05-09 | |||||||||
| 2012-12-31 | $128.57K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $251.14K derived: sum of 2 quarters · filed 2014-03-21 | $328.51K derived: sum of 3 quarters · filed 2014-03-21 | $431.10K 10-K · filed 2014-03-21 | $2.53M 10-K · filed 2013-03-22 | |||||||||
| 2012-09-30 | $122.57K 10-Q · filed 2013-11-13 | $199.94K derived: sum of 2 quarters · filed 2013-11-13 | $302.53K 10-Q · filed 2013-11-13 | $474.40K derived: sum of 4 quarters · filed 2013-11-13 | $2.40M 10-Q · filed 2012-11-08 | |||||||||
| 2012-06-30 | $77.37K 10-Q · filed 2013-08-12 | $179.96K 10-Q · filed 2013-08-12 | $351.83K derived: sum of 3 quarters · filed 2013-08-12 | $550.25K derived: sum of 4 quarters · filed 2013-08-12 | $2.28M 10-Q · filed 2012-08-08 | |||||||||
| 2012-03-31 | $102.59K 10-Q · filed 2013-05-09 | $274.45K derived: sum of 2 quarters · filed 2013-05-09 | $472.88K derived: sum of 3 quarters · filed 2013-05-09 | $576.10K derived: sum of 4 quarters · filed 2013-05-09 | $2.20M 10-Q · filed 2012-05-09 | |||||||||
| 2011-12-31 | $171.86K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | $370.29K derived: sum of 2 quarters · filed 2013-03-22 | $473.51K derived: sum of 3 quarters · filed 2013-03-22 | $546.03K 10-K · filed 2013-03-22 | ||||||||||
| 2011-09-30 | $198.42K 10-Q · filed 2012-11-08 | $301.65K derived: sum of 2 quarters · filed 2012-11-08 | $374.16K 10-Q · filed 2012-11-08 | $466.00K derived: sum of 4 quarters · filed 2012-11-08 | ||||||||||
| 2011-06-30 | $103.22K 10-Q · filed 2012-08-08 | $175.74K 10-Q · filed 2012-08-08 | $267.57K derived: sum of 3 quarters · filed 2012-08-08 | $390.72K derived: sum of 4 quarters · filed 2012-08-08 | ||||||||||
| 2011-03-31 | $72.51K 10-Q · filed 2012-05-09 | $164.35K derived: sum of 2 quarters · filed 2012-05-09 | $287.50K derived: sum of 3 quarters · filed 2012-05-09 | $349.70K derived: sum of 4 quarters · filed 2012-05-09 | ||||||||||
| 2010-12-31 | $91.84K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | $214.98K derived: sum of 2 quarters · filed 2012-03-16 | $277.19K derived: sum of 3 quarters · filed 2012-03-16 | $329.93K 10-K · filed 2012-03-16 | ||||||||||
| 2010-09-30 | $123.15K 10-Q · filed 2011-11-09 | $185.35K derived: sum of 2 quarters · filed 2011-11-09 | $238.09K 10-Q · filed 2011-11-09 | |||||||||||
| 2010-06-30 | $62.21K 10-Q · filed 2011-08-09 | $114.94K 10-Q · filed 2011-08-09 | ||||||||||||
| 2009-12-31 | $100.00K 10-Q · filed 2018-05-04 | $303.22K 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |